What is Dabrafenib?

Category: Prescription Drugs

Most popular types: Tafinlar


Dabrafenib is a generic targeted chemotherapy medication. It is intended for the treatment of melanoma that is BRAF positive.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Dabrafenib

Side effect Patients
Palmar fasciitis 1


Based on patients currently taking Dabrafenib

Dosage Patients
75 mg twice daily 1


Currently taking Dabrafenib

Duration Patients
2 - 5 years 1

What people switch to and from

Patients stopped taking Dabrafenib and switched to:

Treatment Patients
Radioactive iodine (I-131) 1
Last updated:
There are no evaluations for Dabrafenib.